April 28, 2026 · KTOS · RKLB · Gojo

KTOS vs. RKLB: Two Ways to Play Aerospace Growth in 2026

Autonomous warfare vs. space infrastructure — two compelling growth names, two very different risk profiles. Here’s how they stack up.

The Setup

The aerospace sector has one of the most compelling multi-year tailwinds in the market right now: a $1.01T U.S. defense budget (+13.4% proposed), a $1T space economy by 2040 (Morgan Stanley), and geopolitical rearmament driving procurement across NATO and allied nations. The question isn't whether the sector grows — it's which names capture the most upside with manageable downside.

KTOS and RKLB are the two most interesting pure-play growth names outside the mega-primes. But they are not the same trade. KTOS is a defense autonomy and hypersonics play — government contract-driven, already generating over $1.5B in annual revenue, with a concrete near-term catalyst calendar. RKLB is a vertically integrated space infrastructure play — commercially driven, growing at 38% annually, with its entire re-rating thesis resting on one rocket that hasn't flown yet.

You can own both. But you need to know what you're actually buying.

KTOS — Kratos Defense & Security Solutions

Kratos is the defense prime the big primes are afraid of. They build autonomous combat drones (XQ-58A Valkyrie), hypersonic test vehicles, satellite ground systems, and unmanned tactical aircraft — at a fraction of the cost and timeline of traditional defense contractors. The Pentagon noticed. So did the market: KTOS was up 318% over the past 12 months before pulling back 46% from its January 2026 peak of ~$134. It now trades around $62.

The Bull Case

Three growth vectors are converging simultaneously:

  • Valkyrie production ramp: Currently producing ~8 aircraft per year. Target is 40 per year by end of 2028. The initial Drone Dominance Plan Phase 1 award is locked. As production scales, unit economics improve dramatically and the revenue base compounds.
  • Hypersonics doubling: Kratos guided hypersonic revenues to roughly double in 2026 to ~$400M, then grow ~75% again in 2027 to ~$700M. This is the fastest-growing segment in their portfolio and one of the highest-priority programs in the DoD budget.
  • Golden Dome & CCA: The $18B Golden Dome missile defense initiative and the Collaborative Combat Aircraft (CCA) program are direct tailwinds. KTOS was awarded initial MUX TACAIR funding (~$115M for their share) — a program split 50/50 with Northrop Grumman. Additional Golden Dome contract awards expected in 2026.

Full-year 2026 guidance is $1.595B–$1.675B in revenue (+13–19% organic) with a record consolidated backlog of $1.573B and a $13.7B opportunity pipeline. Q1 2026 earnings are May 6 — the first look at how 2026 is tracking.

The Bear Case

Valuation is the primary risk. Even after a 46% drawdown, KTOS trades at a ~119x forward PE. That's pricing in a lot of execution. The company is a single-digit EBITDA margin business right now — growth is real, but profitability leverage takes time. A budget continuing resolution, contract protest, or production delay can hit the stock hard and fast.

The bear case fair value is estimated around $85 — which is ironically above where it trades today, suggesting the market may have overcorrected from the January peak.

KTOS Snapshot
Price (Apr 28) ~$62
52-Week Range $32.68 – $134.00
FY2026 Revenue Guide $1.595B – $1.675B
Backlog $1.573B (record)
Opportunity Pipeline $13.7B
Forward PE ~119x
Key Catalyst Q1 earnings May 6; Golden Dome awards
Analyst Target $135 (KeyBanc Buy — 92% upside)

RKLB — Rocket Lab USA

Rocket Lab is the only vertically integrated space company you can buy on a public exchange that is actually flying rockets. Their Electron small-lift vehicle has completed over 50 missions. Their spacecraft manufacturing division (formerly StellarNet) builds satellites for NASA, the DoD, and commercial operators. And their Neutron medium-lift rocket — the one that would put them in direct competition with SpaceX's Falcon 9 — is targeting a first flight in Q4 2026.

The Bull Case

Revenue is compounding at 38% per year and accelerating. FY2025 came in at a record $602M. Q1 2026 guidance is $185–$200M — a 57% YoY jump at the midpoint. The backlog stands at $1.85B (+73% YoY), and the company just signed an $816M Space Force contract — their largest ever — to design and manufacture 18 satellites for the Tracking Layer Tranche 3 program.

The real re-rating thesis is Neutron. If it flies successfully, Rocket Lab stops being valued as a launch services company and starts being valued as a space platform. The medium-lift market is underserved — SpaceX dominates but is increasingly prioritizing Starship and Starlink. A reliable Neutron at $55M per launch creates a durable alternative that the DoD and commercial operators would pay for.

Path to profitability: management targets FCF positive in 2026, GAAP profitable by 2027–2028.

The Bear Case

The valuation is the problem. At ~48x forward revenue, Rocket Lab is priced for flawless execution in a business that has demonstrated a consistent willingness to slip timelines. Neutron has been delayed from 2024 to 2025 to mid-2026 to now Q4 2026. A stage 1 tank test failure and Archimedes engine qualification delays pushed it again. Each delay burns cash and erodes the narrative.

The SpaceX problem is real too. Falcon 9 has 17,500 kg payload capacity vs. Neutron's 13,000 kg, and SpaceX could cut launch prices to undercut Neutron's $55M target without breaking a sweat. Rocket Lab's moat is customer relationships and faster cadence — not cost leadership.

RKLB Snapshot
Price (Apr 28) ~$82
52-Week Range ~$20 – $105+
FY2025 Revenue $602M (+38% YoY)
Q1 2026 Guide $185–$200M (+57% YoY)
Backlog $1.85B (+73% YoY)
Valuation ~48x forward revenue
Key Catalyst Neutron first flight Q4 2026; Q1 earnings
Analyst Target $86.77 consensus; Stifel $105 (Buy)

Head-to-Head

Dimension KTOS RKLB
Revenue base $1.6B+ (FY2026E), established $750M+ (FY2026E), high growth
Revenue driver DoD contracts, backlog-driven Launch + spacecraft manufacturing
Near-term catalyst May 6 earnings; Golden Dome awards Q1 earnings; Neutron Q4 debut
Valuation ~119x fwd PE — rich but re-rated ~48x fwd revenue — priced for perfection
Drawdown from high −54% from $134 peak Elevated; less pronounced pullback
Profitability Low margins, scaling FCF+ 2026E; GAAP profit 2027–28E
Moat First-to-market autonomous systems, speed Only public vertically integrated space co.
Primary risk Contract delays, budget CR, execution Neutron delays, SpaceX competition
Risk profile Medium-High High

The Verdict

These are not competing picks — they serve different functions in a portfolio. The more interesting trade right now is KTOS. The 46–54% drawdown from the January peak has reset expectations meaningfully. The analyst bear case fair value of ~$85 is above the current price, which tells you the market has oversold the near-term noise. The growth vectors — Valkyrie production, hypersonics doubling, Golden Dome — are concrete and contract-backed, not speculative. Q1 earnings on May 6 are the first catalyst to watch.

RKLB is still a buy on the long thesis, but it deserves a smaller allocation until Neutron flies. At 48x forward revenue, a Q4 Neutron delay — which now has a documented pattern — would reprice the stock fast. The right move is initiating a partial position, holding reserve to add on a Neutron-delay flush, and letting the spacecraft manufacturing revenue compound in the background. The $816M Space Force contract alone validates the spacecraft division as a standalone business.

If you want one: KTOS at $62 is the better entry today — more re-rating already done, concrete near-term catalysts, 92% analyst upside target.
If you want both: KTOS 60% / RKLB 40% weighting, rebalance after Neutron's first flight attempt.

Sources